{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T09:30:18Z","timestamp":1780651818242,"version":"3.54.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:sec><jats:title>OBJECTIVE:<\/jats:title><jats:p>To estimate whether antenatal corticosteroids before 34 weeks of gestation are associated with reduced incidence of respiratory distress syndrome (RDS) and composite neonatal morbidity in preterm twins.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS:<\/jats:title><jats:p>This was a secondary analysis of a multicenter randomized trial for the prevention of preterm birth in multiple gestations. All liveborn, nonanomalous twins delivered between 24 0\/7 and 36 6\/7 weeks of gestation were included. Neonatal outcomes were compared between women who received antenatal corticosteroids and those who did not. The primary outcome was the incidence of RDS. The secondary outcome was the incidence of serious composite neonatal morbidity. Multivariable log Poisson regression with correlation adjustment between twins born to the same mother was performed for confounder control. Adjusted relative risks (RRs) are reported for study outcomes. Based on a post hoc power analysis, this study was powered to detect an RR less than 0.63 for RDS and greater than 1.43 for composite neonatal morbidity outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS:<\/jats:title><jats:p>A total of 432 women (850 neonates) were included. Only 300 (35%) neonates were born to women receiving antenatal corticosteroids. After multivariable regression, antenatal corticosteroids were not associated with a reduced incidence of RDS (81 [27%] compared with 92 [17%] neonates, adjusted RR 1.28, 95% confidence interval [CI] 0.97\u20131.71) or composite neonatal morbidity (87 [29%] compared with 108 [20%] neonates, adjusted RR 1.21, 95% CI 0.93\u20131.56). However, antenatal corticosteroids were associated with increased rates of neonatal intensive care unit admissions (235 [78%] compared with 322 [59%] neonates, adjusted RR 1.22, 95% CI 1.09\u20131.36) and mechanical ventilation (70 [23%] compared with 66 [12%] neonates, adjusted RR 1.52, 95% CI 1.12\u20132.09). Focusing analysis to newborns delivered before 34 weeks of gestation (n=311), 161 (52%) received antenatal corticosteroids. Similarly, no differences in the rate of RDS (66 [41%] compared with 68 [45%] neonates, adjusted RR 1.01, 95% CI 0.76\u20131.34) or composite neonatal morbidity (72 [45%] compared with 81 [54%] neonates, adjusted RR 0.95, 95% CI 0.74\u20131.22) were noted.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSION:<\/jats:title><jats:p>In this cohort of preterm twins, antenatal corticosteroid administration was not associated with a reduced incidence of RDS and composite neonatal morbidity.<\/jats:p><\/jats:sec>","DOI":"10.1097\/aog.0000000000001577","type":"journal-article","created":{"date-parts":[[2016,8,19]],"date-time":"2016-08-19T20:35:50Z","timestamp":1471638950000},"page":"583-591","source":"Crossref","is-referenced-by-count":28,"title":["Antenatal Corticosteroids for the Prevention of Respiratory Distress Syndrome in Premature Twins"],"prefix":"10.1097","volume":"128","author":[{"given":"Oscar A.","family":"Viteri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean C.","family":"Blackwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suneet P.","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerrie S.","family":"Refuerzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Pedroza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximena C.","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baha M.","family":"Sibai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230711","first-page":"1","article-title":"Three decades of twin births in the United States, 1980\u20132009","author":"Martin","year":"2012","journal-title":"NCHS Data Brief"},{"key":"R2-20230711","first-page":"1118","article-title":"Practice Bulletin No. 144. American College of Obstetricians and Gynecologists","volume":"123","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R3-20230711","first-page":"1","article-title":"Births: final data for 2014","volume":"64","author":"Hamilton","year":"2015","journal-title":"Natl Vital Stat Rep"},{"key":"R4-20230711","first-page":"e29","article-title":"Practice Bulletin No. 159. American College of Obstetricians and Gynecologists","volume":"127","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-2007-994355","article-title":"A retrospective analysis of the effect of antenatal steroid administration on the incidence of respiratory distress syndrome in preterm twin pregnancies","volume":"13","author":"Turrentine","year":"1996","journal-title":"Am J Perinatol"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1034\/j.1600-0412.1999.780508.x","article-title":"Antenatal steroids to prevent respiratory distress syndrome: multiple gestation as an effect modifier","volume":"78","author":"Quist-Therson","year":"1999","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000052936","article-title":"Effect of repeated doses of dexamethasone on the incidence and severity of respiratory distress syndrome in multifetal gestation between 24 and 34 weeks","volume":"52","author":"Al-Yatama","year":"2001","journal-title":"Gynecol Obstet Invest"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1067\/mob.2002.123891","article-title":"Cohort study of the neonatal outcome of twin pregnancies that were treated with prophylactic or rescue antenatal corticosteroids","volume":"187","author":"Murphy","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ajog.2004.10.604","article-title":"Plurality-dependent risk of respiratory distress syndrome among very-low-birth-weight infants and antepartum corticosteroid treatment","volume":"192","author":"Blickstein","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1479-828X.2009.00970.x","article-title":"The effect of single or multiple courses of antenatal corticosteroid therapy on neonatal respiratory distress syndrome in singleton versus twin pregnancies","volume":"49","author":"Choi","year":"2009","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMoa070641","article-title":"A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins","volume":"357","author":"Rouse","year":"2007","journal-title":"N Engl J Med"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/0272989X0102100106","article-title":"Prognostic modeling with logistic regression analysis: in search of a sensible strategy in small data sets","volume":"21","author":"Steyerberg","year":"2001","journal-title":"Med Decis Making"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"256.e1","DOI":"10.1016\/j.ajog.2013.06.020","article-title":"Optimal time interval between a single course of antenatal corticosteroids and delivery for reduction of respiratory distress syndrome in preterm twins","volume":"209","author":"Kuk","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1542\/peds.50.4.515","article-title":"A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants","volume":"50","author":"Liggins","year":"1972","journal-title":"Pediatrics"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0002-9378(95)90222-8","article-title":"Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994","volume":"173","author":"Crowley","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"R17-20230711","first-page":"1","article-title":"Effect of corticosteroids for fetal maturation on perinatal outcomes","volume":"12","year":"1994","journal-title":"NIH Consens Statement"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/BF00542524","article-title":"Disposition of betamethasone in parturient women after intravenous administration","volume":"25","author":"Petersen","year":"1983","journal-title":"Eur J Clin Pharmacol"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1067\/mcp.2002.120250","article-title":"Pharmacokinetics of betamethasone in twin and singleton pregnancy","volume":"71","author":"Ballabh","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00563006","article-title":"The placental transfer of betamethasone","volume":"18","author":"Petersen","year":"1980","journal-title":"Eur J Clin Pharmacol"},{"key":"R21-20230711","first-page":"471","article-title":"Placental transfer and metabolism of betamethasone in human pregnancy","volume":"49","author":"Anderson","year":"1977","journal-title":"Obstet Gynecol"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0002-9378(77)90466-5","article-title":"In vitro metabolism of prednisolone, dexamethasone, betamethasone, and cortisol by the human placenta","volume":"127","author":"Blanford","year":"1977","journal-title":"Am J Obstet Gynecol"},{"key":"R23-20230711","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0002-9378(78)90768-8","article-title":"The transfer and metabolism of corticosteroids in the perfused human placenta","volume":"132","author":"Levitz","year":"1978","journal-title":"Am J Obstet Gynecol"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/jps.2600781213","article-title":"Direct radioimmunoassay procedure for plasma dexamethasone with a sensitivity at the picogram level","volume":"78","author":"Lo","year":"1989","journal-title":"J Pharm Sci"},{"key":"R25-20230711","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/S0002-9378(03)00825-1","article-title":"Pharmacokinetics of betamethasone after maternal or fetal intramuscular administration","volume":"189","author":"Moss","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R26-20230711","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-3-642-81265-1_2","article-title":"Delivery and transport of glucocorticoids to target cells","volume":"12","author":"Ballard","year":"1979","journal-title":"Monogr Endocrinol"},{"key":"R27-20230711","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0091-6749(80)90112-8","article-title":"Factors that influence clinical responses to administered corticosteroids","volume":"66","author":"Morris","year":"1980","journal-title":"J Allergy Clin Immunol"},{"key":"R28-20230711","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0002-9378(95)90210-4","article-title":"Scientific basis and therapeutic regimens for use of antenatal glucocorticoids","volume":"173","author":"Ballard","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"R29-20230711","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/bmj.38576.494363.E0","article-title":"Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial","volume":"331","author":"Dalziel","year":"2005","journal-title":"BMJ"},{"key":"R30-20230711","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/S0140-6736(05)66617-2","article-title":"Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial","volume":"365","author":"Dalziel","year":"2005","journal-title":"Lancet"},{"key":"R31-20230711","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/thx.2005.051763","article-title":"Long term effects of antenatal betamethasone on lung function: 30 year follow up of a randomised controlled trial","volume":"61","author":"Dalziel","year":"2006","journal-title":"Thorax"},{"key":"R32-20230711","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/14767050802559095","article-title":"Impact of timing of antenatal corticosteroid exposure on neonatal outcomes","volume":"22","author":"Waters","year":"2009","journal-title":"J Matern Fetal Neonatal Med"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201609000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T23:56:52Z","timestamp":1718755012000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201609000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000001577","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}